« Back to Record
Citation APA

Yang, C. H., Ann-Onda, D., Lin, X., Fynch, S., Nadarajah, S., Pappas, E. G., Liu, X., Scott, J., Oakhill, J. J., Galic, S., Shi, Y.-C., Moreno-Asso, A., Smith, C., Loudovaris, T., Levinger, I., Eizirik, D. L., Laybutt, R. D., Herzog, H., Thomas, H. H., & Loh, K. (2022). Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes. Molecular metabolism, 55, 101413. doi:10.1016/j.molmet.2021.101413


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/340446

Yang, C. H., Ann-Onda, D., Lin, X., Fynch, S., Nadarajah, S., Pappas, E. G., Liu, X., Scott, J., Oakhill, J. J., Galic, S., Shi, Y.-C., Moreno-Asso, A., Smith, C., Loudovaris, T., Levinger, I., Eizirik, D. L., Laybutt, R. D., Herzog, H., Thomas, H. H., & Loh, K. (2022). Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes. Molecular metabolism, 55, 101413. doi:10.1016/j.molmet.2021.101413